Tag: BIRAC
DBT & BIRAC announce a joint call for proposals on Bio-AI...
Bio-AI hubs are proposed to be established across academia and industry to provide critical and novel research leads
India unveils indigenous HPV tests to strengthen cervical cancer screening
Union Minister Dr Jitendra Singh unveils cost-effective, homegrown diagnostic solutions backed by DBT-BIRAC-GCI initiative
Experts discuss IP & tech transfer best practices at World IP...
The event was supported by the National Biopharma Mission, BIRAC, and Institution’s Innovation Council (IIC)
DBT & BIRAC host webinar on biomanufacturing & biofoundry initiative on...
The webinar provided a platform for academia, industry leaders, start-ups, and researchers to discuss advancements, as well as, opportunities in Cell and Gene Therapy
FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular...
Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) talks about the relevance of Startup Mahakumbh event, key factors driving startup ecosystem, latest trends, challenges and much more.
Union govt to collaborate with States to establish regional BIRAC centers...
Mapping of States based on their biotech potential and collaborating to set up Bio E3 Cells
BIRAC Turns 13: Dr Jitendra Singh releases India Bioeconomy Report 2025
India's bio-economy has witnessed a remarkable 16-fold rise in 10 years of the past one decade, from $ 10 Billion in 2014 to an impressive $165.7 Billion in 2024, claimed the Minister
BioVoice eMagazine October 2024 | Issue 6 | Volume 5
The Cover Story focuses on the impact of BIOE3 policy. Read Special Interview of Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research. Expert Insights by Dr Prabhu Vinayagam, Medical Advisor, Orchid AMS and Shashank Avadhani, CEO and Co-founder, Alyve Health. Special stories on MPox virus, AMR and AgriTech.
ASSOCHAM Pharma Summit 2024: Industry experts highlight positioning India as the...
The summit emphasized India's potential as a leader in pharmaceutical innovation, highlighting the need for regulatory reforms, R&D investment, and digital transformation
FACE TO FACE: Davender Kumar Bhati, Co Founder & Director, Invigorate...
In an exclusive rapid-fire interview on the sidelines of Global Bio India 2024 in New Delhi, Davender Kumar Bhati, Co-Founder & Director, Invigorate Biotechnologies shared insights on his company’s key R&D focus areas, startup ecosystem, government policies and much more.